Literature DB >> 3409644

Hepatic alterations in indomethacin-treated rabbits.

G Martines1, L Boiardi, L Butturini, S Bernardi, G Gelmini.   

Abstract

Indomethacin was parenterally administered (6 mg/Kg/day) for 30 days to rabbits, to evaluate changes in serum biochemical parameters and any ultrastructural alterations induced by the drug at the hepatic level. An analysis of the results demonstrated that when the group of rabbits, a statistically significant increase in the serum ALT was found in the treated rabbits. Ultrastructural observations showed the following hepatocyte alterations: 1) minimum mitochondrial alterations 2) mild signs of cholestasis (pericanalicular osmophilic bodies) 3) Smooth endoplasmic reticulum hyperplasia. These findings suggest that indomethacin has the capacity to induce hepatic lesions in the rabbit and this is probably due to the surfactant mechanism.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3409644     DOI: 10.1007/bf02284052

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  9 in total

1.  THE METABOLITES OF INDOMETHACIN, A NEW ANTI-INFLAMMATORY DRUG.

Authors:  R E HARMAN; M A MEISINGER; G E DAVIS; F A KUEHL
Journal:  J Pharmacol Exp Ther       Date:  1964-02       Impact factor: 4.030

2.  The sites of action of indomethacin in rat liver mitochondria.

Authors:  J Z Byczkowski; K Z Korolkiewicz
Journal:  Pharmacol Res Commun       Date:  1977-03

3.  Enzyme diagnosis in hepatic disease.

Authors:  E L Coodley
Journal:  Am J Gastroenterol       Date:  1971-11       Impact factor: 10.864

4.  Diagnostic value of routine liver tests.

Authors:  P Winkel; K Ramsoe; J Lyngbye; N Tygstrup
Journal:  Clin Chem       Date:  1975-01       Impact factor: 8.327

5.  Autoradiographic and biochemical observations on the distribution of non-steroid anti-inflammatory drugs.

Authors:  K D Rainsford; A Schweitzer; K Brune
Journal:  Arch Int Pharmacodyn Ther       Date:  1981-04

6.  Hepatitis with biliverdinaemia in association with indomethacin therapy.

Authors:  F F Fenech; W H Bannister; J L Grech
Journal:  Br Med J       Date:  1967-07-15

7.  Fatal hepatitis probably due to indomethacin.

Authors:  W M Kelsey; M Scharyj
Journal:  JAMA       Date:  1967-02-20       Impact factor: 56.272

8.  Denaturation of cytochrome P-450 by indomethacin and other non-steroidal anti-inflammatory drugs: evidence for a surfactant mechanism and a selective effect of a p-chlorophenyl moiety.

Authors:  M Falzon; A Nielsch; M D Burke
Journal:  Biochem Pharmacol       Date:  1986-11-15       Impact factor: 5.858

9.  Comparative effects of indomethacin on hepatic enzymes and histology and on serum indices of liver and kidney function in the rat.

Authors:  M Falzon; P H Whiting; S W Ewen; A S Milton; M D Burke
Journal:  Br J Exp Pathol       Date:  1985-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.